查找临床试验
已按「肺癌」检索，对应国际通用词 lung cancer
共找到 995 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:08，每 5 分钟自动同步The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
China
年龄 18 Years – 75 Years
Sun Yat-sen University
RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
China
年龄 18 Years – 不限
Xueqin Yang
Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC
China
年龄 18 Years – 不限
The First Affiliated Hospital of Xiamen University
Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
China
年龄 18 Years – 不限
Guangzhou Institute of Respiratory Disease
Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance
China
年龄 30 Years – 80 Years
958th Army Hospital of the Chinese People's Liberation Army
Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
China
年龄 18 Years – 不限
Tianjin Medical University Cancer Institute and Hospital
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
China
年龄 18 Years – 不限
Beijing Tide Pharmaceutical Co., Ltd
TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies
China
年龄 18 Years – 不限
Shenzhen TargetRx Co., Ltd.
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
China
年龄 18 Years – 不限
Suzhou BlueHorse Therapeutics Co., Ltd.
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
China
年龄 18 Years – 80 Years
RenJi Hospital
Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC
China
年龄 18 Years – 75 Years
Beijing Chest Hospital, Capital Medical University
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
China
年龄 18 Years – 不限
Peking Union Medical College Hospital